| Register as an attendee by June 2 at 3:00 p.m . using the following form. |
Young Researchers’ Conference
| → List of Accepted Papers |
| → Rules for Participation |
Presentation
9:00 a.m. – 9:30 a.m.: Reception
9:30 – 9:45: Welcome
-
-
- Scientific Leadership of IBSAL
-
9:45 – 10:00: Presentation by the pre-doctoral community
-
-
- Martín Gómez Redondo
-
Oral Presentations
10:00 a.m. – 12:00 p.m.: Oral Presentations
Moderator: Martín Gómez Redondo
-
-
- Immunological factors predicting disease outcomes and overall survival in common variable immunodeficiency
-
Alba Torres Valle (IIMD-24)
-
-
- Generation of TAT-Cx43266-283- and temozolomide-resistant glioma stem cells
-
Enrique Jiménez Madrona (NEUR-06)
-
-
- Studying the antitumor effect of the cell-penetrating peptide TAT-Cx43mod in a murine model of glioblastoma resection and its tumor microenvironment
-
María Martínez Fernández (NEUR-06)
-
-
- The Urine Proteome as a Window into the Transition from AKI to CKD Following Repeated Episodes of Acute Kidney Injury
-
Joana del Valle Mercado Hernández (CARD-03)
-
-
- High levels of endoglin (CD105) promote the development of cold tumors in a murine model of lung adenocarcinoma
-
Lucía Fernández Frías (CARD-05)
-
-
- The Effect of Mutations in ERCC6L2 and Their Possible Role in Pathogenesis and Predisposition to Germline Myelodysplastic Syndromes
-
Araceli Sama Barroso (CANC-04)
-
-
- VEGF-B as a Treatment in a Model of Early Neurodegeneration
-
Yoan Reynaldo Torres Cruz (TGYC-03)
-
-
- The Relationship Between Sleep Quality and Behavioral Addictions
-
Sara María Vicente Gabriel
Pause
12:00 – 12:30: Coffee
IBSAL Scientific Conference
Presentation
12:30 – 1:00 p.m.: Opening Ceremony
1:00 p.m. – 1:30 p.m.: Report by the Scientific Director of IBSAL
-
-
- Luis García Ortiz
-
1:30 p.m. – 1:45 p.m.: Network of Biomedical Research Institutes in Castile and León
-
-
- Sonia Martín
-
1:45 p.m. – 2:30 p.m.: Presentation of 2024 Projects
Moderator: Pedro Luis Sánchez
-
-
- Diagnostic and Therapeutic Approach to Renal Fragility – Francisco J. López Hernández
-
-
-
- UMBRELLA-SUMMA Legacy: Unified Platform for a Better Comprehensive Evaluation of Myelodysplastic Syndromes in Spain—Strategy for Unraveling Personalized Genomic Medicine in the Public Health System by Incorporating Patient-Reported Outcomes – Mónica del Rey González
-
-
-
- Phase I/II Trial of CARTemis 1, an Optimized, Academic BCMA-Targeted CAR-T Therapy for Relapsed and Refractory Multiple Myeloma – Noemí Puig Morón
-
Pause
2:30 p.m. – 4:00 p.m.: Lunch and poster presentation
Roundtable Discussion: National Science Strategy and Research Evaluation
Moderator: Ángeles Almeida Parra
4:00 p.m. – 4:20 p.m.: Open access to research results
-
-
- Pilar Rico Castro
-
4:20 p.m. – 4:40 p.m.: CoARA: Agreement on the Reform of Scientific Evaluation
-
-
- Pilar Gayoso Diz
-
4:40 p.m. – 5:10 p.m.: Impact Assessment
-
-
- Paula Adam Bernad
-
5:10 p.m. – 5:30 p.m.: Discussion
Overview of Support Services: Platforms
Moderator: Catalina Sanz Lozano
5:30 p.m. – 5:40 p.m.: General presentation
-
-
- Luis García Ortiz
-
5:40 p.m. – 5:50 p.m.: Clinical epidemiology and methodology
-
-
- Ricardo López Pérez
-
5:50 p.m. – 6:00 p.m.: REDCap
-
-
- Cristina Lugones Sánchez
-
6:00 p.m. – 6:10 p.m.: Bioinformatics
-
-
- Carlos Prieto Sánchez
-
6:10 p.m. – 6:20 p.m.: Clinical trials
-
-
- Esperanza López Franco
-
6:20 p.m. – 6:30 p.m.: Biomodels
-
-
- Manuel A. Sánchez Martín
-
6:30 p.m. – 6:40 p.m.: Biobanks
-
-
- Andrés Celestino García Montero
-
Closing Ceremony
18:40: Closing of the conference
-
-
- Pilar Gayoso Diz
-